Watch Now

View All
Understanding Alzheimer’s begins with all of us
Boston University School of Public Health and Savonix are partnering to study how Alzheimer’s develops in adults.

In just 45 minutes, you can help us understand the causes of Alzheimer’s by taking a confidential cognitive test through the Savonix Mobile app. Our aim is to understand how lifestyle choices and social factors affect brain health in adults of all ages and backgrounds.
The History of Savonix
Mylea's grandparents had a ranch where she spent summers running through wheat fields, chasing rabbits, hiding among cornstalks, and swimming in lakes. When her grandfather lost his battle with bone cancer, her grandmother Edna moved in with the family. This is where Savonix first began.
About Savonix
Savonix brings you the world’s first clinical, evidence-based, and all-mobile digital assessment of cognitive and emotional function. For micro-testing at frequent intervals, the test takes as little as three minutes. For a fully integrated neuropsychological battery of 12 domains, testing requires up to 30 minutes. Savonix works with any iOS or Android device and is available via license with healthcare organizations and other third-party partners.

Press Releases

View All
Savonix and Boston University School of Public Health Launch Landmark Population Health Alzheimer’s Disease Discovery Study (ASSIST) to Digitally Collect Brain Health Data
November 4, 2019
Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia
September 17, 2019
Savonix Announces Publication in Cognition, Brain, Behavior
July 8, 2019

In the News

View All
The Funded: New Bay Area IPO filings, $60M in funding deals
August 29, 2019
Savonix adds another $9.6M for cognitive assessment app
April 25, 2019
Women in IT Awards Asia 2019: shortlist revealed for inaugural awards
May 29, 2019

Past Events & Conferences

View All
BIO 2019
Brain Health Panel: Beyond Dementia: The REALLY Big Opportunities in Neuroscience
Jun 4, 2019— 11:00 AM – 12:15 PM ET
Philadelphia Convention Center, 116, Level 100
Global CEO Initiative on Alzheimer’s Disease (CEOi)
Presentation: Scaling Support through Technology
June 5, 2:00 – 5:00 PM
AARP Global Headquarters, 601 E Street, NW, Washington, DC
Global Insurtech Leaders Summit
Panel: What Insurance Innovation for Longevity and Aging Means?
June 19, 2019 — 12:35 – 1:15 PM
One Liberty Plaza, New York, NY